Functional status of platelets in type 2 diabetes patients showing no diabetic fundus changes
Journal Title: Офтальмологический журнал - Year 2017, Vol 0, Issue 1
Abstract
Background: A search for informative indicators of diabetic retinopathy (DR) is important and should be linked to the investigation of potential causes of ocular microcirculation abnormalities. Purpose: To investigate the functional status of platelets in type 2 diabetes mellitus (DM2) patients showing no diabetic fundus changes. Materials and Methods: Thirty eight DM2 patients (38 eyes) manifesting no fundus changes were included in this case-control study. The ophthalmological examination included visual acuity assessment, non-contact tonometry, keratometry and refractometry, anterior eye slit lamp biomicroscopy, retinal wide-angle biomicroscopy, retinal optical coherence tomography and retinal photography. Platelets were isolated by centrifugation of patient’s citrated peripheral blood. The following agonists involved into physiological regulation of hemostasis were used: adenosine diphosphate (ADP; 5 μm), adrenaline (5 μm), angiotensin II (AN-II; 2 μm), platelet activation factor (PAF, 150 μm), and collagen (2 μg/mL). Platelet aggregation was assessed spectrophotometrically with a Chrono-Log aggregometer. Results: Platelets were characterized by specific functional activities of GP VI receptors, α2-adrenoreceptors, АТ1 purine receptors (P2Y12 and P2Y1 receptors) and PAF receptors. Hyperreactivity was a prevailing type of platelet response to agonists. Each type of receptor was characterized by a specific percentage platelet aggregation range related to the greatest share of patients under investigation: collagen, 80-90%; adrenaline, 75-80%; AN-II, 70-80%; ADP, 60-65% and PAF, 60-65%. If persistent, platelet hyperreactivity to one or more agonists can lead to thrombogenesis and ocular microcirculation abnormalities. Conclusion: The analysis of functional reactivity of platelets would provide insight into the clusters of functional activity of platelet receptors which are capable of maintaining the platelet proaggregation status and causing abnormalities in ocular microcirculation, and thus causing progression of DR. Further studies of platelets in vitro may be scientifically beneficial in permitting analysis of the development and progression of diabetic retinopathy.
Authors and Affiliations
A. Hudz, S. Mogilevskyy, M. Maksymtsiv
Keywords
Related Articles
- EP ID EP245050
- DOI -
- Views 114
- Downloads 0
Assessing OCTA changes in morphology and structure of retinal microvascular bed in patients with exudative AMD
Background: Optical coherence tomography angiography (OCTA) enables measuring characteristics of the retinal microvascular bed such as vascular plexus density and foveal avascular zone (FAZ) area. Purpose: To assess the...
Changes in the retinal thickness after microinvasive vitrectomy with inner limiting membrane removal in patients with diabetic retinopathy
The purpose. To study changes in the macular retinal thickness in patients with diabetic retinopathy after microinvasive vitrectomy with inner limiting membrane (ILM) removal. Material and Methods. This was a retrospect...
A method of primary microsurgical debridement of lacrimal canaliculus ruptures in eyelid injuries
Eyelid injuries with the rupture of lacrimal canaliculi are most common for injuries to the lacrimal drainage system and make up approximately 47-48 % of all eyelid injuries. In the absence of correctly-performed primary...
Activity of plasminogen activator inhibitor-1 in blood of patients with metabolic syndrome depending on a stage of diabetic retinopathy
Background. The main cause for the development of proliferative diabetic retinopathy (DRP) is the absence of capillary perfusion, resulting in the initiation of retinal neovascularization. In ischemia reperfusion injury...
Mobility of oculomotor system and lability of visual analyzer in patients with primary open-angle glaucoma
Purpose: to perform a comparative assessment of oculomotor system mobility and visual system lability in patients with primary open-angle glaucoma (POAG) of stages II and III with compensated IOP. Material and Methods:...